Zobrazeno 1 - 10
of 303
pro vyhledávání: '"Te Marvelde J"'
Autor:
Lhermitte, Ludovic, Barreau, Sylvain, Morf, Daniela, Fernandez, Paula, Grigore, Georgiana, Barrena, Susana, de Bie, Maaike, Flores-Montero, Juan, Brüggemann, Monika, Mejstrikova, Ester, Nierkens, Stefan, Burgos, Leire, Caetano, Joana, Gaipa, Giuseppe, Buracchi, Chiara, da Costa, Elaine Sobral, Sedek, Lukasz, Szczepański, Tomasz, Aanei, Carmen-Mariana, van der Sluijs-Gelling, Alita, Delgado, Alejandro Hernández, Fluxa, Rafael, Lecrevisse, Quentin, Pedreira, Carlos E., van Dongen, Jacques J.M., Orfao, Alberto, van der Velden, Vincent H.J., van Dongen, J. J.M., Bitter, W.M., Lubbers, B.R., Teodosio, C.I., Zlei, M., van der Sluijs-Gelling, A.J., de Bie, F., de Bruin-Versteeg, S., van der Burg, M., Schilham, M.W., van der Velden, V. H.J., Langerak, A.W., te Marvelde, J., Bras, A.E., Schilperoord-Vermeulen, J., Jugooa, R., Heezen, K.C., Orfao, A., Almeida, J., Vidriales, M.B., Flores-Montero, J., Pérez-Andrés, M., Matarraz, S., Martín, L., Lecrevisse, Q., Pérez-Morán, J.J., Puig, N., Almeida, A. Medina, Gomes da Silva, M., Faria, T., Brüggemann, M., Ritgen, M., Szczepanowski, M., Kohlscheen, S., Laqua, A., Harbst, E., Finke, J., Asnafi, V., Lhermitte, L., Duroyon, E., Trka, J., Hrusak, O., Kalina, T., Mejstrikova, E., Novakova, M., Thurner, D., Kanderova, V., Szczepanski, T., Sędek, L., Bulsa, J., Slota, L., Kulis, J., Pedreira, C.E., da Costa, E. Sobral, Nierkens, S., de Jong, A., de Koning, A., Lima, M., Santos, A.H., Böttcher, S., Lange, S., Engelmann, R., Paape, D., Machka, C., Gaipa, G., Burracchi, C., Bugarin, C., Lopez-Granados, E., del Pino Molina, L., Campos-Guyotat, L., Aanei, C., Miguel, J. F. San, Paiva, B., Burgos, L., Villamor-Casas, N., Magnano, L., Philippé, J., Bonroy, C., Denys, B., Willems, A., Breughe, P., de Wolf, J., Sousa, A.E., Silva, S.L., Fernandez, P., Morf, D.
Publikováno v:
In Modern Pathology January 2021 34(1):59-69
Autor:
Veenbergen S; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Jugooa R; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Te Marvelde J; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., de Vries ACH; Department of Pediatrics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., van der Velden VHJ; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2024 Aug; Vol. 65 (8), pp. 1186-1189. Date of Electronic Publication: 2024 Apr 08.
Autor:
van der Velden VHJ; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Preijers F; Department of Laboratory Medicine - Laboratory for Hematology, Radboudumc, Nijmegen, The Netherlands., Johansson U; Laboratory Medicine, SI-HMDS, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK., Westers TM; Department of Hematology, Amsterdam UMC, location VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Dunlop A; Department of Haemato-Oncology, Royal Marsden Hospital, Sutton, Surrey, UK., Porwit A; Department of Clinical Sciences, Division of Oncology And Pathology, Faculty of Medicine, Lund University, Lund, Sweden., Béné MC; Hematology Biology, Nantes University Hospital and CRCINA, Nantes, France., Valent P; Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., Te Marvelde J; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Wagner-Ballon O; Department of Hematology and Immunology; and Université Paris-Est Créteil, Assistance Publique-Hôpitaux de Paris, University Hospital Henri Mondor, Inserm U955, Créteil, France., Oelschlaegel U; Department of Internal Medicine, University Hospital Carl-Gustav-Carus, Dresden, TU, Germany., Saft L; Department of Clinical Pathology and Oncology, Karolinska University Hospital and Institute, Solna, Stockholm, Sweden., Kordasti S; Comprehensive Cancer Centre, King's College London and Hematology Department, Guy's Hospital, London, UK., Ireland R; Comprehensive Cancer Centre, King's College London and Hematology Department, Guy's Hospital, London, UK., Cremers E; Department of Internal Medicine, Division of Hematology, Maastricht University Medical Center, AZ, Maastricht, The Netherlands., Alhan C; Department of Hematology, Amsterdam UMC, location VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Duetz C; Department of Hematology, Amsterdam UMC, location VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Hobo W; Department of Laboratory Medicine - Laboratory for Hematology, Radboudumc, Nijmegen, The Netherlands., Chapuis N; Assistance Publique-Hôpitaux de Paris. Centre-Université de Paris, Cochin Hospital, Laboratory of Hematology and Université de Paris, Institut Cochin, INSERM U1016, CNRS UMR8104, Paris, France., Fontenay M; Assistance Publique-Hôpitaux de Paris. Centre-Université de Paris, Cochin Hospital, Laboratory of Hematology and Université de Paris, Institut Cochin, INSERM U1016, CNRS UMR8104, Paris, France., Bettelheim P; Department of Internal Medicine, Ordensklinikum Linz Barmherzige Schwestern - Elisabethinen, Linz, Austria., Eidenshink-Brodersen L; Hematologics Inc, Seattle, WA, USA., Font P; Department of Hematology, Hospital General Universitario Gregorio Marañon-IiSGM, Madrid, Spain., Loken MR; Hematologics Inc, Seattle, WA, USA., Matarraz S; Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytometry Service, University of Salamanca, Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto Carlos III, Salamanca, Spain., Ogata K; Metropolitan Research and Treatment Centre for Blood Disorders (MRTC Japan), Tokyo, Japan., Orfao A; Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytometry Service, University of Salamanca, Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto Carlos III, Salamanca, Spain., Psarra K; Immunology Histocompatibility Department, Evangelismos Hospital, Athens, Greece., Subirá D; Flow Cytometry Unit. Department of Hematology, Hospital Universitario de Guadalajara, Guadalajara, Spain., Wells DA; Hematologics Inc, Seattle, WA, USA., Della Porta MG; IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy & Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy., Burbury K; Department of Haematology, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia., Bellos F; MLL Munich Leukemia Laboratory, Munich, Germany., Weiß E; MLL Munich Leukemia Laboratory, Munich, Germany., Kern W; MLL Munich Leukemia Laboratory, Munich, Germany., van de Loosdrecht A; Department of Hematology, Amsterdam UMC, location VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Publikováno v:
Cytometry. Part B, Clinical cytometry [Cytometry B Clin Cytom] 2023 Jan; Vol. 104 (1), pp. 15-26. Date of Electronic Publication: 2021 Dec 11.
Autor:
Porwit A; Division of Oncology and Pathology, Department of Clinical Sciences, Faculty of Medicine, Lund University, Lund, Sweden., Béné MC; Hematology Biology, Nantes University Hospital, CRCINA Inserm 1232, Nantes, France., Duetz C; Department of Hematology, Amsterdam UMC, VU University Medical Center Cancer Center Amsterdam, Amsterdam, The Netherlands., Matarraz S; Cancer Research Center (IBMCC-USAL/CSIC), Department of Medicine and Cytometry Service, Institute for Biomedical Research of Salamanca (IBSAL) and CIBERONC, University of Salamanca, Salamanca, Spain., Oelschlaegel U; Department of Internal Medicine, University Hospital Carl-Gustav-Carus, TU Dresden, Dresden, Germany., Westers TM; Department of Hematology, Amsterdam UMC, VU University Medical Center Cancer Center Amsterdam, Amsterdam, The Netherlands., Wagner-Ballon O; Department of Hematology and Immunology, Assistance Publique-Hôpitaux de Paris, University Hospital Henri Mondor, Créteil, France.; Inserm U955, Université Paris-Est Créteil, Créteil, France., Kordasti S; Comprehensive Cancer Centre, King's College London, London, UK., Valent P; Department of Internal Medicine I, Division of Hematology & Hemostaseology and Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., Preijers F; Laboratory of Hematology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Alhan C; Department of Hematology, Amsterdam UMC, VU University Medical Center Cancer Center Amsterdam, Amsterdam, The Netherlands., Bellos F; MLL Munich Leukemia Laboratory, Munich, Germany., Bettelheim P; Department of Hematology, Ordensklinikum Linz, Elisabethinen, Linz, Austria., Burbury K; Department of Haematology, Peter MacCallum Cancer Centre, & University of Melbourne, Melbourne, Australia., Chapuis N; Laboratory of Hematology, Assistance Publique-Hôpitaux de Paris, Centre-Université de Paris, Cochin Hospital, Paris, France.; Institut Cochin, INSERM U1016, CNRS UMR, Université de Paris, Paris, France., Cremers E; Division of Hematology, Department of Internal Medicine, Maastricht University Medical Center, Maastricht, The Netherlands., Della Porta MG; IRCCS Humanitas Research Hospital, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Milan, Italy., Dunlop A; Department of Haemato-Oncology, Royal Marsden Hospital, London, UK., Eidenschink-Brodersen L; HematoLogics, Inc., Seattle, Washington, USA., Font P; Department of Hematology, Hospital General Universitario Gregorio Marañon-IiSGM, Madrid, Spain., Fontenay M; Laboratory of Hematology, Assistance Publique-Hôpitaux de Paris, Centre-Université de Paris, Cochin Hospital, Paris, France.; Institut Cochin, INSERM U1016, CNRS UMR, Université de Paris, Paris, France., Hobo W; Department of Internal Medicine I, Division of Hematology & Hemostaseology and Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., Ireland R; Department of Haematology and SE-HMDS, King's College Hospital NHS Foundation Trust, London, UK., Johansson U; Laboratory Medicine, SI-HMDS, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK., Loken MR; HematoLogics, Inc., Seattle, Washington, USA., Ogata K; Metropolitan Research and Treatment Centre for Blood Disorders (MRTC Japan), Tokyo, Japan., Orfao A; Cancer Research Center (IBMCC-USAL/CSIC), Department of Medicine and Cytometry Service, Institute for Biomedical Research of Salamanca (IBSAL) and CIBERONC, University of Salamanca, Salamanca, Spain., Psarra K; Department of Immunology - Histocompatibility, Evangelismos Hospital, Athens, Greece., Saft L; Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital and Institute Solna, Stockholm, Sweden., Subira D; Department of Hematology, Flow Cytometry Unit, Hospital Universitario de Guadalajara, Guadalajara, Spain., Te Marvelde J; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Wells DA; HematoLogics, Inc., Seattle, Washington, USA., van der Velden VHJ; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Kern W; MLL Munich Leukemia Laboratory, Munich, Germany., van de Loosdrecht AA; Department of Hematology, Amsterdam UMC, VU University Medical Center Cancer Center Amsterdam, Amsterdam, The Netherlands.
Publikováno v:
Cytometry. Part B, Clinical cytometry [Cytometry B Clin Cytom] 2023 Jan; Vol. 104 (1), pp. 27-50. Date of Electronic Publication: 2022 Dec 20.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sędek Ł; Department of Microbiology and Immunology, Medical University of Silesia in Katowice (SUM), 41-808 Zabrze, Poland., Flores-Montero J; Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytometry Service (NUCLEUS), University of Salamanca (USAL), 37007 Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.; Center of Biomedical Network Research in Cancer (CIBER ONC), Carlos III Institute of Health, 28029 Madrid, Spain., van der Sluijs A; Department of Immunology, Leiden University Medical Center (LUMC), 2300 RC Leiden, The Netherlands., Kulis J; Department of Pediatric Hematology and Oncology, Medical University of Silesia in Katowice (SUM), 41-800 Zabrze, Poland., Te Marvelde J; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, 3015 CN Rotterdam, The Netherlands., Philippé J; Department of Diagnostic Sciences, Ghent University, 9000 Ghent, Belgium., Böttcher S; Special Hematology Laboratory, Medical Clinic III, Hematology, Oncology and Palliative Medicine, Rostock University Medical Center, 18057 Rostock, Germany., Bitter M; European Scientific Foundation for Laboratory Hemato Oncology (ESLHO), 2333 ZA Leiden, The Netherlands., Caetano J; Clinical Flow, Hemato-Oncology Unit, Champalimaud Foundation, 1400-038 Lisboa, Portugal., van der Velden VHJ; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, 3015 CN Rotterdam, The Netherlands., Sonneveld E; Princess Maxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., Buracchi C; Pediatric Clinic of Milano-Bicocca, Tettamanti Research Center, Monza (TRC), 20900 Monza, Italy., Santos AH; Department of Hematology, Central Hospital of Porto (CHP), 4099-001 Porto, Portugal., Lima M; Department of Hematology, Central Hospital of Porto (CHP), 4099-001 Porto, Portugal., Szczepański T; Department of Pediatric Hematology and Oncology, Medical University of Silesia in Katowice (SUM), 41-800 Zabrze, Poland., van Dongen JJM; Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytometry Service (NUCLEUS), University of Salamanca (USAL), 37007 Salamanca, Spain.; Department of Immunology, Leiden University Medical Center (LUMC), 2300 RC Leiden, The Netherlands., Orfao A; Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytometry Service (NUCLEUS), University of Salamanca (USAL), 37007 Salamanca, Spain.; Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.; Center of Biomedical Network Research in Cancer (CIBER ONC), Carlos III Institute of Health, 28029 Madrid, Spain.
Publikováno v:
Cancers [Cancers (Basel)] 2022 Jan 18; Vol. 14 (3). Date of Electronic Publication: 2022 Jan 18.
Autor:
de Winter DTC; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. Electronic address: d.t.c.dewinter-2@prinsesmaximacentrum.nl., Langerak AW; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands., Te Marvelde J; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands., Dworzak MN; Department of Pediatrics, St. Anna Children's Hospital and Children's Cancer Research Institute, Medical University of Vienna, Vienna, Austria., De Moerloose B; Department of Pediatric Hematology and Oncology, Ghent University Hospital, Ghent, Belgium; Cancer Research Institute Ghent, Belgium., Starý J; Department of Pediatric Hematology and Oncology, University Hospital Motol, Prague, Czech Republic., Locatelli F; Department of Pediatric Hematology and Oncology, IRCCS Bambino Gesù Children's Hospital, Sapienza, University of Rome, Italy., Hasle H; Department of Pediatrics, Aarhus University Hospital Skejby, Aarhus, Denmark., de Vries ACH; Department of Pediatric Hematology and Oncology, Erasmus MC, Sophia Children's Hospital, Rotterdam, the Netherlands., Schmugge M; Department of Hematology and Oncology, University Children's Hospital, Zurich, Switzerland., Niemeyer CM; Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, University of Freiburg, Freiburg, Germany., van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van der Velden VHJ; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Publikováno v:
Leukemia research [Leuk Res] 2021 Sep; Vol. 108, pp. 106652. Date of Electronic Publication: 2021 Jun 29.
Autor:
Mendonça de Pontes R; Internal Medicine Postgraduate Program, Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-617, Brazil.; Cytometry Service, Institute of Paediatrics and Puericultura Martagão Gesteira (IPPMG), Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-912, Brazil., Flores-Montero J; Translational and Clinical Research Program, Cancer Research Center (IBMCC, USAL-CSIC), Cytometry Service (NUCLEUS) and Department of Medicine, University of Salamanca, Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) (CB16/12/00400, CB16/12/00233, CB16/12/00369, CB16/12/00489 and CB16/12/00480), Instituto Carlos III, 28029 Madrid, Spain., Sanoja-Flores L; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) (CB16/12/00400, CB16/12/00233, CB16/12/00369, CB16/12/00489 and CB16/12/00480), Instituto Carlos III, 28029 Madrid, Spain.; Institute of Biomedicine of Seville, Department of Hematology, University Hospital Virgen del Rocío of the Consejo Superior de Investigaciones Científicas (CSIC), University of Seville, 41013 Seville, Spain., Puig N; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) (CB16/12/00400, CB16/12/00233, CB16/12/00369, CB16/12/00489 and CB16/12/00480), Instituto Carlos III, 28029 Madrid, Spain.; Service of Hematology, University Hospital of Salamanca (USAL) and IBSAL, 37007 Salamanca, Spain., Pessoa de Magalhães RJ; Department of Internal Medicine, University Hospital Clementino Fraga Filho, Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-617, Brazil., Corral-Mateos A; Translational and Clinical Research Program, Cancer Research Center (IBMCC, USAL-CSIC), Cytometry Service (NUCLEUS) and Department of Medicine, University of Salamanca, Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) (CB16/12/00400, CB16/12/00233, CB16/12/00369, CB16/12/00489 and CB16/12/00480), Instituto Carlos III, 28029 Madrid, Spain., Salgado AB; Internal Medicine Postgraduate Program, Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-617, Brazil., García-Sánchez O; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) (CB16/12/00400, CB16/12/00233, CB16/12/00369, CB16/12/00489 and CB16/12/00480), Instituto Carlos III, 28029 Madrid, Spain.; Service of Hematology, University Hospital of Salamanca (USAL) and IBSAL, 37007 Salamanca, Spain., Pérez-Morán J; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) (CB16/12/00400, CB16/12/00233, CB16/12/00369, CB16/12/00489 and CB16/12/00480), Instituto Carlos III, 28029 Madrid, Spain.; Service of Hematology, University Hospital of Salamanca (USAL) and IBSAL, 37007 Salamanca, Spain., Mateos MV; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) (CB16/12/00400, CB16/12/00233, CB16/12/00369, CB16/12/00489 and CB16/12/00480), Instituto Carlos III, 28029 Madrid, Spain.; Service of Hematology, University Hospital of Salamanca (USAL) and IBSAL, 37007 Salamanca, Spain., Burgos L; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) (CB16/12/00400, CB16/12/00233, CB16/12/00369, CB16/12/00489 and CB16/12/00480), Instituto Carlos III, 28029 Madrid, Spain.; Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), Clínica Universidad de Navarra, 31008 Pamplona, Spain., Paiva B; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) (CB16/12/00400, CB16/12/00233, CB16/12/00369, CB16/12/00489 and CB16/12/00480), Instituto Carlos III, 28029 Madrid, Spain.; Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), Clínica Universidad de Navarra, 31008 Pamplona, Spain., Te Marvelde J; Department of Immunology, Erasmus MC, (EMC) University Medical Center Rotterdam, 3015 GA Rotterdam, The Netherlands., van der Velden VHJ; Department of Immunology, Erasmus MC, (EMC) University Medical Center Rotterdam, 3015 GA Rotterdam, The Netherlands., Aguilar C; Department of Hematology, Hospital General de Santa Bárbara, 42005 Soria, Spain., Bárez A; Department of Hematology, Complejo Asistencial de Ávila, 05071 Ávila, Spain., García-Mateo A; Department of Hematology, Complejo Asistencial de Segovia, 40002 Segovia, Spain., Labrador J; Department of Hematology and Research Unit, Hospital Universitario de Burgos, 09006 Burgos, Spain., Leoz P; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) (CB16/12/00400, CB16/12/00233, CB16/12/00369, CB16/12/00489 and CB16/12/00480), Instituto Carlos III, 28029 Madrid, Spain.; Service of Hematology, University Hospital of Salamanca (USAL) and IBSAL, 37007 Salamanca, Spain., Aguilera-Sanz C; Department of Hematology, Hospital El Bierzo, 24404 Ponferrada, Spain., Durie B; Cedars-Sinai Samuel Oschin Cancer Center, Los Angeles, CA 90048, USA., van Dongen JJM; Department of Immunology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands., Maiolino A; Internal Medicine Postgraduate Program, Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-617, Brazil.; Department of Internal Medicine, University Hospital Clementino Fraga Filho, Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-617, Brazil.; Americas Centro de Oncologia Integrado, Rio de Janeiro 22290-030, Brazil., Sobral da Costa E; Internal Medicine Postgraduate Program, Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-617, Brazil.; Cytometry Service, Institute of Paediatrics and Puericultura Martagão Gesteira (IPPMG), Faculty of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-912, Brazil., Orfao A; Translational and Clinical Research Program, Cancer Research Center (IBMCC, USAL-CSIC), Cytometry Service (NUCLEUS) and Department of Medicine, University of Salamanca, Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) (CB16/12/00400, CB16/12/00233, CB16/12/00369, CB16/12/00489 and CB16/12/00480), Instituto Carlos III, 28029 Madrid, Spain.
Publikováno v:
Cancers [Cancers (Basel)] 2021 Apr 03; Vol. 13 (7). Date of Electronic Publication: 2021 Apr 03.
Autor:
Hofste op Bruinink D; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Laboratory Medical Immunology, Department of Immunology, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands . d.hofsteopbruinink@erasmusmc.nl., Oliva S; Myeloma Unit, Division of Hematology, University of Torino, Torino, Italy., Rihova L; Department of Hematology, University Hospital Brno, Brno, Czech Republic., Schmitz A; Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark., Gilestro M; Myeloma Unit, Division of Hematology, University of Torino, Torino, Italy., Te Marvelde J; Laboratory Medical Immunology, Department of Immunology, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands., Kralova R; Department of Hematology, University Hospital Brno, Brno, Czech Republic., Høholt H; Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark., Broijl A; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Johnsen HE; Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark., Hajek R; Department of Hemato-oncology, University Hospital Ostrava and Faculty of Medicine, Ostrava University, Ostrava, Czech Republic., Boccadoro M; Myeloma Unit, Division of Hematology, University of Torino, Torino, Italy., Sonneveld P; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Omedè P; Myeloma Unit, Division of Hematology, University of Torino, Torino, Italy., Van der Velden VHJ; Laboratory Medical Immunology, Department of Immunology, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands . v.h.j.vandervelden@erasmusmc.nl.
Publikováno v:
Haematologica [Haematologica] 2020 Oct 05; Vol. 106 (5), pp. 1496-1499. Date of Electronic Publication: 2020 Oct 05.